In CF, HMGB-1 may increase pulmonary inflammation by attracting neutrophils [34], preventing their efferocytosis [39] and amplifying the effects of bacterial lipopolysaccharide and cytosine-phosphatidyl-guanosine-DNA constructs [40]. Here, HMGB1 is linked to cystic fibrosis.